CDMO News
Viralgen Partners with Broad Institute to Develop Gene Therapy for Prion Disease
Viralgen, a leader in AAV gene therapy manufacturing, has joined forces with two labs from the prestigious Broad Institute of MIT and Harvard University to develop an innovative treatment for prion disease. This partnership brings together expertise in gene therapy
9 January 2025